Last update 07 Jun 2025

Fonadelpar

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fonadelpar (USAN/INN), EYEN 520, EYEN-520
+ [5]
Target
Action
agonists
Mechanism
PPARδ agonists(Peroxisome proliferator-activated receptor delta agonists)
Therapeutic Areas
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC25H23F3N2O4S
InChIKeyWWKYLBGQYALEDL-UHFFFAOYSA-N
CAS Registry515138-06-4

External Link

KEGGWikiATCDrug Bank
D10880--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dry Eye SyndromesPhase 3
United States
20 Aug 2018
Corneal epithelial defectPhase 2
United States
08 Apr 2014
Corneal epithelial degenerationPhase 2
United States
08 Apr 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
130
(Placebo)
ldpgvzgsgl = ccmlsypxfv mnjzhkjkpk (cgbgpmzfgl, rmpacpvtdl - xmvwyslwpg)
-
12 Jun 2018
(0.0002% SJP-0035 Ophthalmic Solution)
ldpgvzgsgl = uesnsfdftx mnjzhkjkpk (cgbgpmzfgl, ogyqliyjew - lubldxjwza)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free